q&_OqUm&%51o6kb")uwY;QN`6O?diD_}fYo!ze3'-#rS[K7d4_o[fcpK%`hZ_E_6[9[~a]/*ek~pRMGw,}e2~Z{x/)2|eW.e|~B;S_K^.?u=t|&,->W/3U,B)/K4wY=( S|']rJ;q Originally posted here:
tYIKPB^BX[qDzd|j}fuI]]7:6]W?F}nj .aj"p=<=]G3H!/5d4TAe E &f3Yw!H*tV<.tHK6+{TUY[3q{!@.}qCU/0H/(/NK XmkmoBf !9`7]#Fq7+[8b8"9#]@HCPrTr.SbDW$e|+5]/$OlY!Dus_[(n0y-!*U i~h[k>~$%q/t$rk0wz]9dpB`~5B>5
oj/T|T[IJ:V`oy4i%;T^fBR5. Ox|XOz~ufnqq?8N7)[ ;7o`w|b}s;{J[|A=XDD+_DJ/=KCSJg^{/;-AE6rJsK]I SVpl:vBUu1Gd.ux
KpR0}*L/HmI9WXIE[_mjL]u}S:fh}gMYD@Kf.gfePp$~Lp-ap`jvw v>b0Ge5{?rB&/Cc=yQx1$:EDk6zm`g`TUGMJ61[*J}JV7Y;2s$k]6lF]?"Aq-eYzWx'>"qcRBGoC_$a rA'0o^M h|+jkW-Gp&ojsrK} igk;~ 7YxSK$.}6w|ks2_msg,lA"$8Q Q]~2QN%]Ri_s;075TpQH7}?t)t kG~.P138u=? 1 Fn4ykv5.c>UOx/x* #+v)8'G!-d:7z}pF64g^?(g39qN3.Ac b7[_M*2 &U*_!q$w_5>)JF+$|`I? S@lgCL._f.yv~JS> jt_tj@z)ONvy(m:%euGsF[19"l`;;O16F&[T#YK}S1|` vG6R<;l^Cn&C.+r
Grey's Anatomy Recap: The First Time - Vulture
Author Archives: Fredricko
Life after Grey’s: TR Knight has kept busy since leaving Seattle – EW.com (blog)
For more from T.R. Knight on his return to Shondaland, pick up the new issue of Entertainment Weekly on stands Friday, orbuy it here now and subscribe for more exclusive interviews and photos, only in EW.
Nearly a decade after T.R. Knight endured a snowballing scandal and a dramatic exit from Greys Anatomy, hes back in the last place youd expect Shondaland.
Next month, Knight joins the cast of The Catch as the brother of Mireille Enos Alice Vaughan, landing him back in the land that made him a household name. But what has Knight been up to in the years since he left Greys Anatomy? Below is but a taste of what the actorhas done.
Law & Order: SVU (2011)
Knight took a dark turn as a set of twins on opposite ends of the spectrum one, a family man, the other, a serial rapist. One of the twins especially creeped the s out of me, frankly, Knight says. Everyone was lovely on the project, but that was yuck, what a horrible person that guy was. That was one [where] you want to have a hot shower afterward and just scrub with bleach.
RELATED: Greys Anatomy: Before They Were Stars
The Good Wife (2013)
That was crazy because we shot that about five blocks away from where I was living at the time in Brooklyn, says Knight, who calls scheming political operative Jordan Karahalios a s stirrer. Knight also jokes Jordan was likely adopted. My little weird face, theres not much that says Greek about that, he says. Alas, Knight has not been asked to appear on spinoff The Good Fight.
42 (2013)
Playing a real-life character in the Jackie Robinson flick meant researching the world of 1940s baseball to best honor the legacy of Dodgers publicity chief Harold Parrott. There are some jobs that just make you wake up in the morning and you cant believe that youre a part of it; that was one of those, Knight says.
Its Only a Play (2015)
Reuniting with Nathan Lane after co-starring in the short-lived CBS sitcom Charlie Lawrence, Knight had to strip down to his skivvies for this Broadway play. Theres some exposed tuckus in that and not necessarily the most comfortable thing for me. Theres some people who get hired to take off their clothes and its not for laughs I dont know what thats like, Knight says with a chuckle. Youre not going to hire me to come out of the shower like Eric Dane.
RELATED: Hear more of the latest TV news from this week
11/22/63 (2016)
Hulus James Franco-starring time-travel piece about the JFK assassination felt much like a play to Knight, as his character had one long scene they blocked in a single take. But what stuck with him was returning to that fateful location. We got to shoot on Dealey Plaza, which was a very eerie and emotional experience, Knight says.
When We Rise (2017)
In another case of playing a real-life figure, Knight has a role in ABCs upcoming Dustin Lance Black docudrama chronicling the struggle of the modern gay rights movement. To have a small part of telling that kind of epic story of gay rights, womens rights, and civil rights all coming together in this one story I cant wait to see it, Knight says, lauding co-star Guy Pearce. I just admire his work a lot. Hes a strong character and such a good guy. It was great to act with him.
The Catch (2017)
The Greys Anatomy alum morphs into the self-serving brother of Alice Vaughan for his triumphant return to Shondaland. We were doing our first Broadway shows at the same time, Knight says of Enos. I saw her in Whos Afraid of Virginia Woolf? and then, of course, through The Killing. Its nice when you have acting impressions of people, then you get to finally act with them; that made it very exciting for me.
The Catch returns Thursday, March 9 at 10 p.m. ET on ABC. Knight discusses his debut here.
Read the rest here:
Life after Grey's: TR Knight has kept busy since leaving Seattle - EW.com (blog)
‘Grey’s Anatomy’ Star Rips ‘The Real O’Neals’ For Bisexual Joke – Huffington Post
Sara Ramirez, who is bisexual and played a bisexual surgeon on Greys Anatomy, had a bone to pick with The Real ONeals.
The actress blasted the sitcom Thursday over a Jan. 17 episode in which a gay character played by Noah Galvin likened bisexuality to having webbed toes or money problems, several outlets noted.
The 41-year-old actor, who came out last October, implored network ABC and The Real ONeals on Twitter to own and address the issue and empower LGBTQ youth with accurate positive reflections.
Ramirez said shes disappointed in the network for which she worked for 10 years on the doctor drama. She left the show in May. I will invest my brand where Im respected, she wrote.
Rodin Eckenroth via Getty Images
Galvin and Parents and Friends of Lesbians and Gays, known as PFLAG and which partnered with The Real ONeals on the episode, issued apologieslast month for causing offense, the New York Daily News reported. A PFLAG spokeswoman said that the group blew it for not catching the comment earlier.
But in another tweet Ramirez called for a network response.
The actress also encouraged followers to sign a change.org petition protesting the show.
Originally posted here:
'Grey's Anatomy' Star Rips 'The Real O'Neals' For Bisexual Joke - Huffington Post
Scoop: GREY’S ANATOMY on ABC – Thursday, March 9, 2017 – Broadway World
Civil War Richard, Jackson, April and Catherine tackle a grueling trauma case intensified by hospital politics. Amelia finally faces her feelings about Owen, and Meredith gets caught between Nathan and Alex over a patient, on Greys Anatomy, THURSDAY, MARCH 9 (8:00-9:01 p.m. EST), on the ABC Television Network.
Greys Anatomy stars Ellen Pompeo as Meredith Grey, Justin Chambers as Alex Karev, Chandra Wilson as Miranda Bailey, James Pickens Jr. as Richard Webber, Kevin McKidd as Owen Hunt, Jessica Capshaw as Arizona Robbins, Jesse Williams as Jackson Avery, Sarah Drew as April Kepner, Caterina Scorsone as Amelia Shepherd, Camilla Luddington as Jo Wilson, Jerrika Hinton as Stephanie Edwards, Kelly McCreary as Maggie Pierce, Jason George as Ben Warren, Martin Henderson as Nathan Riggs and Giacomo Gianniotti as Andrew DeLuca.
Guest starring is Debbie Allen as Catherine Avery and Marika Dominczyk as Eliza Minnick.
Greys Anatomy was created and is executive produced by Shonda Rhimes (Scandal, How to Get Away with Murder), Betsy Beers (Scandal, How to Get Away with Murder), Mark Gordon (Saving Private Ryan) and Rob Corn (Chicago Hope). William Harper, Stacy McKee, Zoanne Clack and Debbie Allen are executive producers. Greys Anatomy is produced by ABC Studios.
Civil War was written by Elizabeth J.B. Klaviter and directed by Nicole Rubio.
Greys Anatomy is broadcasted in 720 Progressive (720P), ABCs selected HTV format, with 5.1-channel surround sound.
Excerpt from:
Scoop: GREY'S ANATOMY on ABC - Thursday, March 9, 2017 - Broadway World
Rare Muscle Disease Treated Successfully with Gene Therapy – Genetic Engineering & Biotechnology News
Work on gene therapy is showing significant progress for restoring muscle strength and prolonging lives in dogs with a previously incurable, inherited neuromuscular disease, according to scientists at the University of Washington (UW) Medicine Institute for Stem Cell and Regenerative Medicine.
The disease arises from a mutation in genes that normally make myotubularin, a protein essential for proper muscle function. Puppies with this naturally occurring mutation exhibit several features of babies with the same defective gene. The rare disorder, called X-linked myotubular myopathy, or XLMTM, affects only males. It causes fatal muscle wasting. Both dogs and boys with the disease typically succumb in early life due to breathing difficulties.
For decades, researchers have struggled to find suitable treatments for genetic muscle diseases like this one. Collaborating research groups in the United States and France found a way to safely replace the disease-causing MTM gene with a healthy gene throughout the entire musculature of affected dogs.
Their most recent findings ("Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs") werepublished online inMolecular Therapy.The paper reports that diseased dogs treated with a single infusion of the corrective therapy were indistinguishable from normal animals 1 year later.
"This regenerative technology allowed dogs that otherwise would have perished to complete restoration of normal health," said Martin K. "Casey" Childers, Ph.D., UW medicine researcher and physician. Dr. Childers is a professor of rehabilitation medicine at the University of Washington School of Medicine and co-director of the Institute for Stem Cell and Regenerative Medicine.
Gene therapy holds the promise to treat many inherited diseases. To date, this approach has not been widely translated into treatment of skeletal muscle disorders.
"We report here a gene therapy dose-finding study in a large animal model of a severe muscle disease where a single treatment resulted in dramatic rescue," said Dr. Childers. The findings demonstrate potential application across a wide range of diseases and broadly translate to human studies. The data supports the development of gene therapy clinical trials for myotubular myopathy, the researchers concluded.
The study was conducted in collaboration with Harvard University, Medical College of Wisconsin, Virginia Tech, INSERM, and Genethon.
Excerpt from:
Rare Muscle Disease Treated Successfully with Gene Therapy - Genetic Engineering & Biotechnology News
To prevent serious medical conditions, scientists should be able to edit people’s DNA, panel says – Los Angeles Times
Scientists should be allowed to altera persons DNA in ways that will be passed on to future generations, but only to prevent serious and strongly heritable diseases, according to a new report from the National Academy of Sciences and the National Academy of Medicine.
However, tinkering with these genes in orderto enhance or alter traits such as strength, intelligence or beauty should remain off-limits, the report authors concluded.
Changing theso-called germline effectively, editing humanitys future by altering genes in human reproductive cells is illegal in the United States. It has largely been considered ethically off-limits here as well, at least whilebioethicists and scientists pondered the unforeseen effects and unexamined moral dilemmas of using new gene-editing technologies.
However, scientists have moved forward aggressively to explore the feasibility of altering disease genes in other adult human cells with a revolutionarytechnique known asCRISPR-Cas9. It is widely believed that gene editing of this sort could treat patients with metabolic disorders, certain cancers, anda range of otherdiseases that arise from genetic mutationswithout altering the germline.
Last year, Chinese scientists launched a trial that uses CRISPR-Cas9 in a treatment for lung cancer. While the trials outcome is awaited with high anticipation, scientists outside of China have expressed concern that ethical reservations in the United States and Europe will put themat a disadvantage.
CRISPR-Cas9 makesgene editing more straightforward, more precise and far more widespread. As such, the National Academies report acknowledgesthat changingheritable DNA ineggs, sperm and early embryosis fast becoming a realistic possibility that deserves serious consideration.
The 22-memberpanel of scientists and bioethicists who produced the report completed a comprehensive review of the issues raised by that prospect.
Clinical trials involving germline editing should onlybe pursuedto treat diseases that cannot be improvedwith reasonable alternatives, the committee said. In addition, they added,scientists should convincingly demonstratethey are targeting a gene that eithercauses or strongly predisposes a carrier to a serious disease or condition, and that they have weighed the likely risks and benefits of altering that gene.
These clinical trials should be conducted under public scrutiny that takes into account issues ofsocietal fairness, personal dignityand scientific integrity, the panel said.
Finally, scientists should conduct long-term follow-up studies to discern how gene editing affects subsequent generations.Public debate and discussion about the technologyshould continue, the panel added.
Genome editing research is very much an international endeavor, and all nations should ensure that any potential clinical applications reflect societal values and be subject to appropriate oversight and regulation, saidMIT cancer researcher Richard O.Hynes, who co-chaired the panel with University of Wisconsin-Madison bioethicist R. Alta Charo. These overarching principles and the responsibilities that flow from them should be reflected in each nations scientific community and regulatory processes.
Dr. J. Patrick Whelan, an immunologist and bioethicist who was not on the panel, said the grouphas asked the compelling questions, sparkinga conversation that must keep up with a rapid pace of scientific discovery in this field. He called the reportsrelease a fantastic development.
What theyre saying is, lets start the conversation, maintain ethical structures along the way, and hopefully do this the right way, said Whelan, who serves on the advisory board of USCs Institute for Advanced Catholic Studies.
The international panel included members from the U.S., China, France, Israel andItaly.Their report was underwritten in part by the Department of Defenses Advanced Research Projects Agency and the U.S. Food and Drug Administration.
Follow me on Twitter @LATMelissaHealy and "like" Los Angeles Times Science & Health on Facebook.
MORE IN SCIENCE
El Nio triggered unprecedented erosion across California's coast
Heres what the president of MIT thinks of the Trump administrations early moves
African penguins are being trapped by climate change
See more here:
To prevent serious medical conditions, scientists should be able to edit people's DNA, panel says - Los Angeles Times
New amination chemistry brought to light – Chemical & Engineering News (subscription)
Flashes of light help chemists at Princeton University and Bristol-Myers Squibb drive the hydroaminations of olefins to produce substituted amines. The light-powered reaction gives chemists another tool for installing amines in drugs and other biologically important molecules.
The new hydroamination is noteworthy for its intermolecular reactivity, its use of unactivated olefin substrates, its toleration of several different functional groups, and its regioselectivity for anti-Markovnikov amine productswherein the new CN bond forms on the less substituted carbon of the olefin (Science 2017, DOI: 10.1126/science.aal3010). Most other examples of hydroaminations result in products with the opposite, Markovnikov regiochemistry. Whats more, the new reaction can produce highly substituted amines (such as in the example shown) that are impossible to make any other way.
In the reaction, irradiation of a secondary alkyl amine in the presence of an iridium catalyst and a thiol cocatalyst yields an aminium radical cation intermediate. This species is responsible for the reactions anti-Markovnikov regiochemistry and highly substituted products, explains Robert Knowles, who led the research effort. These alkyl aminium radical cations are highly reactive and will add to many olefin classes with extraordinarily fast rates, allowing us to achieve these types of intermolecular hydroaminations. he says.
Knowles came up with an elegant approach to what was really an unsolved problem, comments Kami L. Hull, an expert in anti-Markovnikov hydrofunctionalization at the University of Illinois, Urbana-Champaign. Previous examples of anti-Markovnikov hydroaminations, she points out, either required activated olefins or directing groups, or produced stoichiometric amounts of unwanted by-products. Furthermore, Hull adds, Knowless olefin substrates are so energetically stable that they wouldnt react without his photocatalytic approach, which really expands what chemists can do with this reaction.
Link:
New amination chemistry brought to light - Chemical & Engineering News (subscription)
Bristol university chemistry lab evacuated in explosive scare … – The Guardian
Bristol skyline. Photograph: Alamy
A university building was evacuated after a student accidentally made the same explosive that was used in the Paris terror attacks.
The University of Bristol said triacetone triperoxide (TATP) was unintentionally formed in its chemistry laboratory on 3 February.
Police, fire service and bomb disposal experts were called to the building and carried out a controlled explosion of the substance. No one was injured in the incident.
TATP was used in bomb vests worn by militants in the attacks that killed 130 people in November 2015.
A university spokesperson said: Following a full investigation, we can confirm that the chemical triacetone triperoxide (TATP) was unintentionally formed during a routine procedure carried out by a PhD student.
The student was following a published literature method and the risk of TATP as a potential byproduct had been identified during the risk assessment process.
They added: We have robust contingency plans in place to deal with incidents of this nature. As soon as the presence of TATP was identified, the student immediately notified those responsible for laboratory safety in the school.
A series of actions were then taken which resulted in the precautionary evacuation of the chemistry building and surrounding buildings and the controlled disposal of the substance by the emergency services.
The spokesperson said the chemistry departments risk assessment process was being reviewed to determine whether additional checks could be made.
See the original post:
Bristol university chemistry lab evacuated in explosive scare ... - The Guardian
Learning chemistry within Minecraft video game — ScienceDaily – Science Daily
Science Daily | Learning chemistry within Minecraft video game -- ScienceDaily Science Daily Scientists are exploring whether teaching real-world science through a popular computer game may offer a more engaging and effective educational approach ... |
See more here:
Learning chemistry within Minecraft video game -- ScienceDaily - Science Daily
UCD department of chemistry hosts Miller Symposium – Davis Enterprise
The UC Davis department of chemistry is hosting the 17th annual R. Bryan Miller Symposium on Thursday and Friday, March 16-17, at the UCD Conference Center off Old Davis Road.
The Miller Symposium celebrates the contributions of UCD professor R. Bryan Miller, who laid the foundation for the departments thriving pharmaceutical chemistry and chemical biology programs. The symposium features invited speakers from industry and academia from across the country who will share cutting-edge research that will interface between chemistry, biology and medicine.
In addition, the student poster session and opening receptions, coffee breaks and lunch provide ample time for networking.
This event is open to the public, and all proceeds from ticket sales will benefit poster awards and scholarships for undergraduate and graduate students, as well as ensure continuation of the conference. Tickets range from $10 for UCD students to $50 for faculty and staff to $75 for the general audience.
For more information and to register, visit http://www.conferences.ucdavis.edu/miller.
View original post here:
UCD department of chemistry hosts Miller Symposium - Davis Enterprise
Maastricht, the Netherlands, Selected to Host European Congress on Biotechnology 2020 – Exhibitor Online
2/16/2017 The Executive Board of the European Federation of Biotechnology has selected Maastricht as the host city for their flagship congress from 28 June 1 July, 2020. The European Congress on Biotechnology is the longest established congress in biotechnology and attracts 1,000+ delegates from academia and industry. The scientific programme covers the spectrum of biotechnologies, reflecting the EFBs mission to promote the safe, sustainable and ethical use of biological systems for the benefit of mankind.
Jeff Cole, Vice President, EFB and Chair of the Congress Organising Committee, announced the win for Maastricht, saying Following a competitive process, we are delighted to confirm Maastricht as our host destination for ECB 2020. We were particularly impressed with the Local Organising Committee members from the Dutch Biotechnology Society who have committed their time and connections to ensure we have an outstanding scientific programme and the essential support of industry. The strength of Maastricht as a biotechnology hub will undoubtedly be an attraction for our delegates.
Caroline Windsor, TFI Group - professional conference organiser for the EFB added Maastricht is a superb location for ECB 2020. The MECC lends itself to our congress requirements including integrated space for exhibition, posters and catering as well as multiple auditoria for concurrent sessions. The city is compact with a good choice of hotels and social programme venues for networking out of conference hours.
The bid was led by Jurgen Moors, Managing Director, Maastricht Convention Bureau and Jordy Rijksen, Business Development Manager, Maastricht MECC. They reacted to the news by saying On behalf of the city of Maastricht and the Maastricht Convention Bureau we can state we are pleased to hear that Maastricht has officially been selected as destination for the 2020 edition of the ECB. This underlines that everything our city has to offer, the proactive local congress community and the fact that the Maastricht Region is internally recognised as a main European hub in the field of biotechnology were main decisive criteria for the Executive Board of the European Federation of Biotechnology.
The scientific ambassadors for the bid, Prof. Aldrik Velders, Chair of the BioNanoTechnology Group at Wageningen University, and Dr Emile van de Sandt, Director Research & Development of DSM Sinochem Pharmaceuticals, added The Dutch Society of Biotechnology is very pleased to host the ECB2020. With our strong academic and industrial network we are looking forward to organising an inspiring conference that will bring together scientists from all over Europe that are active in the more established as well as emerging fields of Biotechnology.
The biennial European Congress on Biotechnology circulates to cities that are centres of excellence in biotechnology. The ECB2018 congress will be in Geneva from 1 4 July 2018: for more information, see http://www.ecb2018.com.
The Maastricht Convention Bureau is the intermediary to promote convention and meeting visits to Maastricht and surroundings. Our goal is to make a structural contribution to the economic development of Maastricht and surroundings. The Maastricht Convention Bureau office is situated in building where the offices of MECC Maastricht are located as well. The complete address details are: Maastricht Convention Bureau | Duboisdomein 5b | 6229 GT MAASTRICHT | THE NETHERLANDS
Contact: info@maastrichtconventionbureau.com
Visit link:
Maastricht, the Netherlands, Selected to Host European Congress on Biotechnology 2020 - Exhibitor Online
The biotechnology trial of the century over CRISPR patent settled in US court – NEWS.com.au
CRISPR is a life-changing genetic modification technology that could potentially cure cancer and eradicate genetic conditions before a child is born. But there is a dark side to the potential of this technology.
The patent dispute over CRISPR technology has been settled.
AN INFLUENTIAL US science advisory committee this week said genetic modification of human embryos should be allowed in the future to eliminate diseases, sparking new debate on a controversial topic.
The report by the National Academy of Sciences (NAS) caused concern among some researchers who fear that genetic tools could be used to boost certain peoples intelligence or create people with particular physical traits.
Clinical trials for genome editing of the human germ line adding, removing or replacing DNA base pairs in gametes or early embryos could be permitted in the future, said the report, released Wednesday (AEST).
But only, it added, for serious conditions under stringent oversight.
The emergence of inexpensive and accurate gene-editing technology, known as CRISPR/Cas9, has fuelled an explosion of new research opportunities and potential clinical applications, both heritable and non-heritable, to address a wide range of human health issues, the report said.
The committee of international experts was convened to examine scientific, ethical and governance issues surrounding human genome editing.
The experts noted that clinical trials on gene editing for certain non-hereditary traits are already under way.
These therapies affect only the patient, not any offspring, and should continue for treatment and prevention of disease and disability, using the existing ethical norms and regulatory framework for development of gene therapy, it said.
There is plenty of concern about the designer human floodgates opening.Source:YouTube
The warning come as a major patent battle over the technology was settled in the US in recent days.
What many described as the biotechnology trial of the century, the Broad Institute won the patent to the popular gene-editing process known as CRISPR/Cas-9.
The legal battle over who really invented the technology pitted Feng Zhang of the Broad Institute a research facility affiliated with Harvard University and the Massachusetts Institute of Technology against French microbiologist Emmanuelle Charpentier of the Max Planck Institute in Berlin and biochemist Jennifer Doudna of the University of California, Berkeley.
Both sides claimed to have developed CRISPR-Cas9, which allows scientists to edit stretches of the genome by removing, adding or changing pieces of the DNA sequence.
Jennifer Doudna of UC Berkeley ultimately lost out in the dispute.Source:Getty Images
Scientists say the technology has the potential to cure diseases but also raises ethical questions, particularly when it comes to the prospect of forever altering the human race.
Charpentier and Doudna have won multiple prizes in the past four years and were widely considered to have discovered this gene-editing technique. Their work was first published in the journal Science in June 2012.
This important decision affirms the inventiveness of the Broads work in translating the biology of the natural world into fundamental building blocks to create unprecedented medicines, said a statement by Katrine Bosley, president and chief executive officer of Editas Medicine, which has an exclusive licence on the Broad Institutes patent for human-therapy applications.
The Atlantic magazine described Editas Medicine as the biggest winner.
Assuming the patent decision does not change, Editas will be the major player in human CRISPR therapies in the foreseeable future, it said.
Follow three people who hope the mapping of the human genome will transform their lives. Will the Human Genome Project change our relationship with ourselves forever?
See the original post here:
The biotechnology trial of the century over CRISPR patent settled in US court - NEWS.com.au
Two Indian American Post-grads Named Gates Cambridge Scholars – India West
At least two Indian American post-graduate students were named among the 2017 class of Gates Cambridge Scholars at the University of Cambridge, the university announced in a Feb. 8 news release.
A total of 36 scholars were named including Sarita Deshpande and Angela Madira.
Deshpande is currently studying bioengineering with a concentration in cellular and tissue engineering at the University of Illinois at Chicago.
As an undergraduate student, she engaged in neuroscience and bioengineering research, which fostered her passion to study ocular pathology in the scope of neuroscience, she said in her scholar bio.
She will study M.Phil in medical science at Lucy Cavendish College in the Department of Clinical Neurosciences.
During the scholar year, she will study the aetiology of glaucoma and the mechanisms of cell death, which can provide further insight into developing novel therapeutic options.
"I am honored and excited to join the dynamic group of scholars that make up the Gates Cambridge community," she said.
Madira, who was also named an Amgen Scholar in 2015, will be just 17 when she starts her M.Phil in health, medicine and society at Newnham College, becoming the first genuine millennial Gates Cambridge Scholar.
She began her B.Sc. in biochemistry at California State University in Los Angeles at the age of 12 and is about to publish a paper on the removal of dermoid cysts based on clinical research at the L.A. Children's Hospital.
Her M.Phil dissertation will focus on the efficacy and ethics of existing mammalian research models.
She hopes to target the philosophy of cognitive psychology through the multispecies interactions between humans and animals, particularly scientists and their test subjects. She plans to become a pediatric neurosurgeon.
My undergraduate career has led me to a unique journey committed to unlocking the secrets of the human brain while constantly contemplating the meaning of ethics in the fields of research and medicine, she said in her profile. I have had the opportunity to study neuroscience from a molecular, physiological, and clinical perspective. In the future, I hope to use this knowledge to explore neurological disorders in children.
The Gates Cambridge U.S. Scholars-elect, who will take up their awards beginning in October, are from 34 universities, including three which have never before had a Gates Cambridge Scholar Mississippi State University, California State University Los Angeles and Loyola University in New Orleans.
The scholars will study and research subjects ranging from collaborative songwriting to improving health outcomes, spider behavior, voter analytics to cancer therapeutics targeting the side effects associated with chemotherapy, the university said.
The prestigious postgraduate scholarship program which fully funds postgraduate study and research in any subject at the University of Cambridge was established through a $210 million donation to the University of Cambridge from the Bill and Melinda Gates Foundation in 2000.
Since its 2001 inception, there have been more than 1,600 Gates Cambridge Scholars from 104 countries who represent more than 600 universities globally and 80 academic departments and all 31 colleges at Cambridge.
The 36 U.S. Scholars-elect will join 54 Scholars from other parts of the world, who will be announced in early April after interviews in late March and will complete the class of 2017.
Read the rest here:
Two Indian American Post-grads Named Gates Cambridge Scholars - India West
Grey’s Anatomy’s Civil War Just Took on Collateral Damage & Eliza Will Never Be the Same – E! Online
ABC
If Grey's Anatomy fans didn't like Eliza Minnick before tonight, they probably hate her now.
The brash doctor (played by Marika Dominczyk) brought in to overhaul Grey-Sloan Memorial's teaching program went full throttle with her plans by placing particular surgeries in the unprepared hands of attendings, leaving the residents to simply observe and guide. Because this is Shondaland, the results were calamitous, resulting in Edwards (Jerrika Hinton) accidentally killing one of Arizona's (Jessica Capshaw) pediatric patients when she misses the fact that the kid's bleeding internally. Making matters even worse, when a distraught Edwards looked to her budding mentor for guidance, Eliza just abandoned her in the hallway to go have a meltdown of her own.
In short, it was not her finest moment.
But it just might be the thing needed to change her aloof and abrasive ways, Dominczyk told E! News."It was such a big event for her to reflect on herself and think about, you know, maybe her approach isn't the best," she admitted. "And I think it makes her take a moment to reflect on who she is, what she really wants, the good that she wants to do and how to do that without making things bad. It knocks her down. It definitely knocks her down a lot of pegs and she has to build herself up again and push through it and, in a way, still be confident and not let it ruin her. Because it's such a huge thing that happened that she didn't foreshadow. She didn't see it coming at all."
Another thing she didn't see coming? Just how much her failure to react properly would push Edwardsone of Minnick's biggest supporters among the attendings up until that momentback into Webber's (James Pickens Jr.) arms (literally) as she was looking for guidance.
"I think that after Eliza deals with how it makes her feel as a doctor and how it affects her, so she can get over that huge hurdle, then she can look around at the damage that it's caused around. And I think that sheit's not like she was building momentum in a good way, anyway," Dominczyk added. "It's kind of like maybe starting from ground zero and doing it over, but maybe with kinder hands, maybe gentler. Being more socially aware of how she comes off when she does stuff like that, you know? I think that initially when she blows off Edwards, it doesn't have anything to do with Edwards, which is the main mistake, right? She's supposed to be the teacher and help, but she's so consumed with what happened that she can't even see. She can't even see it yet. I think it hits her when Richard gives her that look. It crushes her because she looks up to Richard and she respects him so much and she wants to be accepted, but still hold her ground and come off as strong. So, it's a balancing act."
ABC
So, could a kinder, gentler Minnick be just the thing to stop this civil war before it consumes the hospital? It couldn't hurt, Dominczyk admitted, but don't expect a miracle."I would say that it makes people take a long hard look at what they're doing and the repercussions of certain actions," she said about how Grey-Sloan moves forward from here. "To slow down a bit and try to do what's best for everybody and not just best for one person. Because at the end of the day, they all want the same thing. They all want the hospital to be the best hospital it could be, and they all want all the attendings to learn everything the proper way and be good doctors. So, it might bring everything together, but not like a 'Kumbaya, we all love Minnick now.' That definitely, unfortunately, doesn't happennot overnight. But it's a step in the right direction."
Despite the disaster of a day, Minnick did find herself in the arms of a sympathetic Arizona out in the parking lot, who reinforces the notion that Eliza could make things easier on herself with everyone if only she'd try. Is romance on the horizon for these two? And how will the other docs respond to Arizona's flirting with the enemy?I think they are drawn to each other and they are cautious, for the right reasons, with how much they let people know because I don't think they know themselves where this is going or what's going to happen," Dominczyk teased."You're just going to have to watch and see this cautious circling. They're only human, so people do slip up sometimes."
This being Grey's Anatomy, expect the slip up sooner rather than later.
Where do you stand on Minnick after her big screw-up? Let us know in the comments below.
Grey's Anatomy airs Thursdays at 8 p.m. on ABC.
E! Online - Your source for entertainment news, celebrities, celeb news, and celebrity gossip. Check out the hottest fashion, photos, movies and TV shows!
Read more from the original source:
Grey's Anatomy's Civil War Just Took on Collateral Damage & Eliza Will Never Be the Same - E! Online
Doctors call for revising syllabus of anatomy – Times of India
NAGPUR: Various issues on revision of anatomy syllabus, including assessment of manpower and duration of teaching, came up for discussion during a conclave organized by the department of anatomy of NKP Salve Institute of Medical Sciences and Research Centre recently.
The topic of the conclave was 'Challenges in anatomy curriculum and way ahead.' Dr DD Ksheersagar was the organizing secretary. Ninety-two delegates from Central India participated in the continuing medical education (CME) programme and discussed various issues on revision of the syllabus of anatomy that also highlighted modification in theory, practical examination, curricular reforms for histology, embryology, gross anatomy and genetics.
Dr Mangala Kohli, head of the anatomy department, Vardhaman Mahavir Medical College, New Delhi, was the chief guest. Dr MD Huddar introduced Dr Kohli. Dr Ksheersagar welcomed the chief guest and other dignitaries and explained the purpose of holding the CME. Dr Kohli stressed the need for reforms in anatomy curriculum and improving job opportunities for anatomists. Ranjeet Deshmukh, chairman of VSPMAHE, congratulated Dr Ksheersagar for organizing the CME.
Go here to see the original:
Doctors call for revising syllabus of anatomy - Times of India
Chemistry Seminar by Fr. Gerald Buonopane – Seton Hall University News & Events
Wednesday, February 15, 2017
By Nicholas Snow
The Department of Chemistry and Biochemistry Rose Mercadante Seminar Series is pleased to present a seminar entitled "Effect of Cold Plasma Processing on Sweet Basil and the Chemistry of its Essential Oils" by Fr. Gerald Buonopane, Dr. Cosimo Antonacci and Dr. Jose Lopez of the Departments of Chemistry and Biochemistry and Physics of Seton Hall University.
The seminar will take place in the Helen Lerner Amphitheater, Science and Technology Center, Seton Hall University at 5:45 P.M. on Tuesday February 21, 2017. Refreshments are available at 5:30 PM.
This interdisciplinary research project, which focuses on the emerging field of plasma agriculture, seeks to better understand the chemical and physical effects of cold plasma processing on plants and their essential oils. Cold plasma processing has been shown to be a rapid, economical, and pollution-free method to improve plant seed performance and crop yield. Essential oils are aromatic oily liquids extracted from different parts of plants, such as the leaves, flowers, and roots. Among the various beneficial properties of essential oils is their demonstrated antioxidant effect directly applicable to foods that are prone to oxidative consequences such as poor flavor, bad odors, and spoilage. Antioxidants, either synthetic (e.g., butylated hydroxytoluene, BHT) or natural (e.g., Vitamin C), are routinely added to processed foods to inhibit or delay oxidation. Essential oils are examples of natural antioxidants. Although synthetic antioxidants like BHT and BHA (butylated hydroxyanisole) are very effective, they have been shown to be potentially harmful to human health with demonstrated evidence of causing cancer in laboratory animals. As a result, food scientists have been seeking alternative natural compounds as substitute antioxidants, such as essential oils. We have observed a growth effect in our preliminary studies treating basil plants with cold plasmas. We have also observed that plasma treatment increases the antioxidant activity of essential oils. Our preliminary work further revealed a difference in the composition of individual antioxidant components between the plasma-treated and non-plasma-treated basil. In follow-up studies, we seek to better understand cold plasma's physical and biochemical-molecular effects on basil plants.
Ordained as a priest of the Archdiocese of Newark in 2006, Fr. Gerry's area of specialization is food chemistry. He earned a B.S. in Biology from Northeastern University (1978), a M.S. in Nutritional Science from the University of Connecticut (1981) and a Ph.D. in Food Science from Penn State University (1988). Prior to seminary and the priesthood, Fr. Gerry held a number of positions in academia, the federal government (USFDA), and in the food and pharmaceutical industries. His research areas of interest are: Chemical Deterioration of Food Lipids: Oxidative Reactions; Essential Oils as Natural Antioxidants; and Cold Plasma Treatment of Botanicals and Essential Oils.
Dr. Cosimo Antonacci holds BS and PhD degrees in Chemistry from Seton Hall University. He is currently Undergraduate Laboratory Manager in the Department of Chemistry and Biochemistry, where he supervises all activities in the department's teaching laboratories. He is an active researcher in biochemistry with ongoing collaborations in Biochemistry, Biological Sciences and Physics.
Professor Jose L. Lopez is an Associate Professor in the Department of Physics at Seton Hall University in South Orange, New Jersey, USA. He earned a B.S. in Physics from Saint Peter's University in Jersey City, New Jersey in 2000, an M.S. in Physics in 2003 and a Ph.D. in Physics in 2006 from the Stevens Institute of Technology in Hoboken, New Jersey.
Categories: Science and Technology
For more information, please contact:
Excerpt from:
Chemistry Seminar by Fr. Gerald Buonopane - Seton Hall University News & Events
The Olivia Nelson-Ododa Blog: Season-ending injury, staying positive, Grey’s Anatomy and more – USA TODAY High School Sports
The Olivia Nelson-Ododa Blog: Season-ending injury, staying positive, Grey's Anatomy and more USA TODAY High School Sports Winder-Barrow (Winder, Ga.) forward Olivia Nelson-Ododa is the top ranked player in the ESPN HoopGurlz 100 for 2018 and has everyone from Connecticut to South Carolina to Maryland and many others all giving chase. Now Nelson-Ododa has agreed to ... |
Bones amid the stones: Anatomy of a murder – Bay Net
La Plata, MD - As the first-degree murder trial of Raymond Daniel Posey, 24 of Nanjemoy, entered its second week Monday, Feb. 13, one thing is apparent. The physical evidence in the case is slim, mere bones found amid the stones in remote western Charles County. The crux of the states case revolves around testimony of witnesses both willing and unwilling.
Four witnesses testifying for the Charles County States Attorneys Office are current residents of the Charles County Detention Center in La Plata. Although some attorneys refer to the jail as Snitch Central, what those witnesses have to say is just what the state wants the jury to hear.
One testified that Posey confessed to him after 24-year-old Crystal Anderson disappeared July 26, 2011 and was last seen leaving a Nanjemoy party with the defendant and co-defendant Durrell Wilson, Yeah, I busted that bitch.
The states most unwilling witness appeared Monday after practically a full day of testimony from Charles County Sheriffs Office Detective John Elliott that began Feb. 10 and continued Feb. 13.
Elliott had testified that the Prince Georges County Police Department originally investigated the case as a missing person, and local officers just assisted until Andersons remains were discovered by a hunter near Purse State Park in a narrow, steep ravine in January 2012.
Then it became our case because the remains were found here, Elliott explained. The detective said while leads initially were slim, detectives were able to interview co-defendant Wilson, but were unable to interview Posey until his arrest on unrelated robbery charges in October 2012. It took three interviews with the defendant before Elliott finally admitted to Posey that all roads keep leading back to you.
Detectives even threw Posey a curve ball in that third interview, presenting the defendant with a letter supposedly written by the victim's mother, a letter that was actually written by detectives in order to elicit a response.
Elliott said Posey, became visibly upset when he read the letter.
Kearra Bannister was the states most reluctant witness who was subpoenaed to testify and tried unsuccessfully to Plead the Fifth. At first, proceedings involving Elliotts testimony were disrupted when it was discovered Bannister was in the courtroom and wasnt supposed to be.
She left before Charles County Assistant States Attorney Francis Granados pointed out to Charles County Circuit Court Judge H. James West that she was in the courtroom. When she did finally enter the courtroom to testify, it was soon made clear why she was so reluctant to be there. It turns out that Bannister had married Poseys co-defendant, Durrell Wilson, just last Thursday, Feb. 9.
Bannister asked for and was granted a public defender, in this case Charles County Assistant Public Defender Michele Harewood, to discuss her legal rights before she was brought to the stand.
To say that she was an uncooperative witness is an understatement, but Granados persisted with no small degree of skill in squeezing out testimony wherein she reluctantly admitted telling Charles County Sheriffs Office Detective Brion Buchanan in August 2011 that she had seen Crystal Andersons clothing laid out on the bed at Wilsons house following the womans disappearance. She also acknowledged seeing Andersons ID card in the living room. Bannister told the detective the two men sold or gave away the clothing at the Farmer's Market in Charlotte Hall the following Saturday.
Granados finally got Bannister to admit she tried to call Wilson the day after Anderson went missing and was unable to reach him and that when she did, he told her he was "somewhere near a hill," that she heard Posey's voice in the background. Wilson told her he was "looking for something and picking something up."
The state has alleged the two men returned to the scene of the muder the following day to retrieve shell casings.
Why are you asking me all of these questions about my husband? Bannister asked the prosecutor. Its not his trial. West had to admonish the witness several times that the prosecutor was asking the questions, not she, and that she was required to answer the states questions.
She intimated that Wilson and Posey robbed Anderson of money and drugs. Raymond had the water (PCP) and Durrell had the money, she can be heard telling Buchanan in a taped interview. Bannister tried to recant her 2011 interview with the detective, saying, Me and Durrell had a fight and I was mad when I said those things. The damage before the jury, however, was done, and Granados struck at her truthfulness when he asked if she was scared during her interview with the detective.
No, I wasnt scared, she insisted.
Granados played the interview in which she began crying and told the detective, Im scared, okay?
The case is expected to continue through the week.
Contact Joseph Norris at joe.norris@thebaynet.com
Follow this link:
Bones amid the stones: Anatomy of a murder - Bay Net
Metro MediSpa’s Testosterone Therapy Benefits Men’s Hearts – Satellite PR News (press release)
Submit the press release
WILMINGTON, NC, February 15, 2017 Testosterone therapy has now been shown to be beneficial for older men knocking down the long-held assertion that it was detrimental to their hearts. Men can now regain their youthful vitality and ease the symptoms that accompany low testosterone levels.
What is Testosterone Therapy?
Hypogonadism is a disease in which the body is unable to produce normal amounts of testosterone due to a problem with the testicles or with the pituitary gland that controls the testicles. The symptoms of low testosterone include: loss of bone density and muscle mass, increased body fat, osteoporosis, diminished sexual drive, erectile dysfunction, anemia, frailty, depression, and coronary disease. Testosterone therapy is a way for men to improve the signs and symptoms of this disease. By opting for testosterone therapy, men can increase the amount of testosterone in their body up to sufficient levels.
Is it harmful to heart patients?
In the past, it was assumed that testosterone therapy posed potential health risks to men, like heart attacks and strokes. However, this is not true according to the latest research. The researchers at Intermountain Medical Center Heart Institute have presented a new study which deduces that testosterone therapy can help heart patients a great deal. The study shows that heart patients given testosterone therapy showed much better results than the patients not receiving the treatment.
The study further claims that the notion that testosterone therapy increases the risk of heart attacks and strokes is not correct. It discovered that heart patients who did not receive any testosterone therapy were 80% more likely to suffer a heart attack or stroke than the ones who received the therapy.
How was the study conducted?
The study involved 755 male patients suffering from heart disease ranging in age from 58 to 78, and tested the patients in groups of three. Each group was given testosterone therapy in the form of a gel or by injections, and their heart conditions were monitored for possible effects.
The results of this study are a significant leap in medical history. It concludes that contrary to the popular belief that testosterone therapy harms a mans heart, the use of this therapy can be improved or prevent heart disease. This study will help define further medical strategies related to heart conditions and problems. Now older men with low testosterone levels can be treated without fear of causing heart problems and allow them to continue active lifestyles.
Overall, our study suggests that what is best for mens health is to keep testosterone levels balanced and within a normal range, said Dr. Connie Odom.
ABOUT METRO MEDISPA Owned and operated by Connie Odom, M.D., Board Certified Anesthesiologist and American Academy of Anti-Aging Medicine Certified Physician. Metro MediSpa has changed the way cosmetic procedures are performed by introducing the first medically directed mobile spa in the Southeast.
Through anti-aging medicine along with advanced cosmetic treatments, our experienced team of medical professionals is committed to bring the beauty of an improved appearance and an inner age defying wellness to all.
Motivated by the belief that health and wellness affects all areas of ones life and having the knowledge in safe and effective cosmetic treatments, the staff at Metro Medispa can help people correct imperfections that had become uncomfortably noticeable.
Submit the press release
A new study shows that testosterone therapy reduces heart attacks in older men with heart disease.
WILMINGTON, NC, February 15, 2017 Testosterone therapy has now been shown to be beneficial for older men knocking down the long-held assertion that it was detrimental to their hearts. Men can now regain their youthful vitality and ease the symptoms that accompany low testosterone levels.
What is Testosterone Therapy?
Hypogonadism is a disease in which the body is unable to produce normal amounts of testosterone due to a problem with the testicles or with the pituitary gland that controls the testicles. The symptoms of low testosterone include: loss of bone density and muscle mass, increased body fat, osteoporosis, diminished sexual drive, erectile dysfunction, anemia, frailty, depression, and coronary disease. Testosterone therapy is a way for men to improve the signs and symptoms of this disease. By opting for testosterone therapy, men can increase the amount of testosterone in their body up to sufficient levels.
Is it harmful to heart patients?
In the past, it was assumed that testosterone therapy posed potential health risks to men, like heart attacks and strokes. However, this is not true according to the latest research. The researchers at Intermountain Medical Center Heart Institute have presented a new study which deduces that testosterone therapy can help heart patients a great deal. The study shows that heart patients given testosterone therapy showed much better results than the patients not receiving the treatment.
The study further claims that the notion that testosterone therapy increases the risk of heart attacks and strokes is not correct. It discovered that heart patients who did not receive any testosterone therapy were 80% more likely to suffer a heart attack or stroke than the ones who received the therapy.
How was the study conducted?
The study involved 755 male patients suffering from heart disease ranging in age from 58 to 78, and tested the patients in groups of three. Each group was given testosterone therapy in the form of a gel or by injections, and their heart conditions were monitored for possible effects.
The results of this study are a significant leap in medical history. It concludes that contrary to the popular belief that testosterone therapy harms a mans heart, the use of this therapy can be improved or prevent heart disease. This study will help define further medical strategies related to heart conditions and problems. Now older men with low testosterone levels can be treated without fear of causing heart problems and allow them to continue active lifestyles.
Overall, our study suggests that what is best for mens health is to keep testosterone levels balanced and within a normal range, said Dr. Connie Odom.
ABOUT METRO MEDISPA Owned and operated by Connie Odom, M.D., Board Certified Anesthesiologist and American Academy of Anti-Aging Medicine Certified Physician. Metro MediSpa has changed the way cosmetic procedures are performed by introducing the first medically directed mobile spa in the Southeast.
Through anti-aging medicine along with advanced cosmetic treatments, our experienced team of medical professionals is committed to bring the beauty of an improved appearance and an inner age defying wellness to all.
Motivated by the belief that health and wellness affects all areas of ones life and having the knowledge in safe and effective cosmetic treatments, the staff at Metro Medispa can help people correct imperfections that had become uncomfortably noticeable.
Press release service and press release distribution provided by http://www.24-7pressrelease.com
Original post:
Metro MediSpa's Testosterone Therapy Benefits Men's Hearts - Satellite PR News (press release)
Team chemistry has improved 3-point shooting, Kings say – Sacramento Bee
Sacramento Bee | Team chemistry has improved 3-point shooting, Kings say Sacramento Bee Guard Darren Collison seemed surprised when told the Kings' 18 3-pointers in a win over the Atlanta Hawks on Friday night set a franchise record. Especially with all the shooters that's been through this organization, Collison said. You think about ... |
See the original post:
Team chemistry has improved 3-point shooting, Kings say - Sacramento Bee